Navigation Links
Prognostic markers for prostate cancer patients who receive radiation after surgery
Date:11/3/2010

SAN DIEGO, CA (November 3, 2010)Removal of the prostate gland often eradicates early-stage cancer. But patients whose cancer has spread may need to follow up with what is known as salvage radiation therapy. Researchers at Fox Chase have now determined a better way to monitor outcomes after this procedure.

A team led by Mark Buyyounouski, M.D., M.S., radiation oncologist at Fox Chase who will present the results at the annual meeting of the American Society for Radiation Oncology, found that levels of a prostate-specific protein up to 18 months after salvage radiation therapy predict mortality and progression of the disease.

"It's important because if you can identify people who are more likely to die of prostate cancer early, you can talk with them about doing another treatment very quickly, with the hope that it will prolong their lives," says Buyyounouski.

Prostate cancer, the most common cancer in men and the second leading cause of cancer deaths in men, causes nearly 220,000 new cases and more than 30,000 deaths each year. The presence of the disease is indicated by the amount of a protein called prostate-specific antigen (PSA). For men who do not undergo surgery, reaching a PSA level of 2 ng/mL within 18 months after radiation treatment is associated with spread of the disease and higher mortality rates. Buyyounouski and his team were curious about whether the same criterion is important for patients who receive radiation after surgery.

In the study, the scientists looked at 222 patients who went through salvage radiation therapy at Fox Chase between 1991 and 2007. They found that roughly half of the men who surpassed threshold PSA levels in the bloodstream within 18 months after treatment experienced spread of the disease or died within five years. By contrast, men whose PSA levels did not reach the threshold within 18 months did not die within five years, and the likelihood that the disease metastasized was only 17% during that time period. The more quickly the PSA rises, the greater the likelihood the disease will attack other organs and cause death.

"These results provide us with an opportunity to identify patients who should be treated aggressively, before we see any other evidence of prostate cancer," Buyyounouski says. On the other hand, men who approach a PSA level of 2 ng/mL 18 months after treatment or later may not require immediate hormonal therapy, he adds. To confirm the findings, Buyyounouski and his team will next extend the investigation to multiple institutions and a larger set of patients.


'/>"/>

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center
Source:Eurekalert

Related medicine news :

1. A prognostic and predictive biomarker for nonsmall cell lung cancer
2. "IPGDx, LLC Announces The Continued Validation Of Its Patented Technology For The Assessment Of Prognosis; PrognostiCheck" Getting the New Information to Patients and Do
3. Radiation pharmacogenomics identifies biomarkers that could personalize cancer treatment
4. Mayo researchers find biomarkers for personalizing radiation cancer treatment
5. Biomarkers May Aid in Early Diagnosis of Alzheimers
6. NIH launches effort to define markers of human immune responses
7. Biomarkers Could Spot Alzheimers Disease Early, Studies Suggest
8. Hydrophobic proteins: Potential biomarkers for colorectal cancer
9. Genetic markers could predict prostate cancer in younger men, U-M study finds
10. UAB researchers find 4 biomarkers important in colorectal cancer treatment prognosis
11. BATTLE links potential biomarkers to drugs for lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... May 31, 2016 , ... Twenty years ago it was revolutionary: ... trying to silence the voices they hear. But this approach has proven transformative, both ... method has steadily gained credibility and now is used around the world, but it ...
(Date:5/31/2016)... Eden Prairie, MN (PRWEB) , ... May 31, 2016 , ... ... accreditation from the American Association for Laboratory Accreditation (A2LA) to include ISO 594-1 and ... the most common means of achieving a leak-free connection between two medical devices (e.g. ...
(Date:5/31/2016)... ... May 31, 2016 , ... Effective leaders not only drive service ... as a whole. On June 2, Northbound CEO Mike Neatherton and COO Paul Alexander ... presenting the opening plenary on “Leadership: The Journey to Authenticity” with Onsite Workshops CEO ...
(Date:5/31/2016)... ... ... The Global Wellness Summit (GWS), an annual conference for international leaders ... spa and beauty in Europe. The organization asked its partner experts in Europe - ... - to forecast where wellness is headed in Europe. Predictions range from European nations ...
(Date:5/31/2016)... Montana (PRWEB) , ... May 31, 2016 , ... Spectrum ... Lift. This new lift has been designed and built with the user in mind. ... of aquatic consultants have informed us that an ADA 400 lbs lift is a ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... , May 31, 2016 The ... is progressing at a CAGR of 10.6% within a ... valued at US$0.46 bn in 2013. Owing to favorable ... to reach US$0.88 bn by the end of this ... from the market,s holistic representation in a research report ...
(Date:5/31/2016)... ZIONA, Israel , May 31, ... medicine company utilizing its proprietary plant-based rhCollagen technology for ... authorization from the Chief Scientist of Israel,s ... of its NIS 12 million development project for 2016. The ... higher than last year,s authorized grant, which totaled NIS ...
(Date:5/30/2016)... India , May 30, 2016 /PRNewswire/ ... market research report "Healthcare Biometrics Market by ... (Signature, Voice)), Multifactor, Multimodal), Application (Workforce Management), ... Forecast to 2021", published by MarketsandMarkets, the ... Million by 2021 from USD 1,182.6 Million ...
Breaking Medicine Technology: